BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8079919)

  • 21. Hepatitis C virus infection in Egyptian children: single centre experience.
    El-Raziky MS; El-Hawary M; El-Koofy N; Okasha S; Kotb M; Salama K; Esmat G; El-Raziky M; Abouzied AM; El-Karaksy H
    J Viral Hepat; 2004 Sep; 11(5):471-6. PubMed ID: 15357655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of hepatitis C virus infection in a suburban Detroit community.
    Meyer RA; Gordon SC
    Am J Gastroenterol; 1991 Sep; 86(9):1224-6. PubMed ID: 1652886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Vinson S; Mousa M; Gitnick G
    Am J Kidney Dis; 2000 Jan; 35(1):122-9. PubMed ID: 10620553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with severity and disease progression in chronic hepatitis C.
    Tassopoulos NC; Papatheodoridis GV; Katsoulidou A; Delladetsima JK; Sypsa V; Touloumi G; Nikandros M; Hatzakis A
    Hepatogastroenterology; 1998; 45(23):1678-83. PubMed ID: 9840128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study.
    Villari D; Pernice M; Spinella S; Squadrito G; Rodinò G; Brancatelli S; Longo G; Raimondo G
    Am J Gastroenterol; 1995 Jun; 90(6):955-8. PubMed ID: 7771429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia.
    Zhou S; Terrault NA; Ferrell L; Hahn JA; Lau JY; Simmonds P; Roberts JP; Lake JR; Ascher NL; Wright TL
    Hepatology; 1996 Nov; 24(5):1041-6. PubMed ID: 8903372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ; Aardema KL; Burd EM; Nakhleh RE; Brown KA; Abouljoud MS; Hirst K; Moonka DK
    Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers.
    Papatheodoridis GV; Delladetsima J; Verghisi-Nikolakaki S; Malliori M; Krystallis A; Hatzakis A; Tassopoulos NC
    Am J Gastroenterol; 1995 Oct; 90(10):1843-6. PubMed ID: 7572906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
    Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation].
    Sookoian S; Castaño G; Castiglioni T; Pilar S; Viudez P; González J; Frider B
    Medicina (B Aires); 1997; 57(6):699-707. PubMed ID: 9674191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection.
    Hayashi J; Kishihara Y; Yamaji K; Furusyo N; Yamamoto T; Pae Y; Etoh Y; Ikematsu H; Kashiwagi S
    Hepatology; 1997 Mar; 25(3):697-701. PubMed ID: 9049221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV and HCV co-infection: situation at six French university hospitals in the year 2000.
    Buffet-Janvresse C; Peigue-Lafeuille H; Benichou J; Vabret A; Branger M; Trimoulet P; Goria O; Laurichesse H; Abbed A; Verdon R; Bouvet E; Lafon ME; Dussaix E; Cormerais L; Dupon M; Henquell C; Josse A; Lagoutte P; Lariven S; LeGac S; Riachi G; Verdon R; Vittecoq D;
    J Med Virol; 2003 Jan; 69(1):7-17. PubMed ID: 12436472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of chronic coinfection with hepatitis B and C virus on liver histology.
    Sagnelli E; Pasquale G; Coppola N; Scarano F; Marrocco C; Scolastico C; Santantonio T; Gentile A; Piccinino F
    Infection; 2004 Jun; 32(3):144-8. PubMed ID: 15188073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Does serum HCV-RNA-positive hepatitis C differ from serum HCV-RNA-negative hepatitis C?].
    Dällenbach A; Renner EL; Solioz M; Bianchi L; Schmid M; Reichen J
    Schweiz Med Wochenschr; 1995 Oct; 125(40):1855-63. PubMed ID: 7481644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.